フルオレセイン血管造影の市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

フルオレセイン血管造影市場の成長と動向

Grand View Research, Inc.の最新レポートによると、フルオレセイン血管造影の世界市場規模は、2025～2030年にかけてCAGR 8.5%で拡大し、2030年末までに13億9,000万米ドルに達する見込みです。

黄斑変性症や糖尿病性網膜症などの眼科疾患の有病率の増加や急速な技術進歩は、インパクトの大きい市場促進要因の一部です。しかし、OCTや眼底自発蛍光など、より安全で迅速な代替手段への嗜好の高まりが、予測期間中の市場成長を阻害すると予想されます。

国内の病院や画像診断センターなどのエンドユーザーは、様々な失明の原因となる疾患を検出するためにAIベースの眼底カメラを効果的に採用しています。例えば、2019年1月、広東省の徳清県病院は、Sun Yat-sen UniversityとBaidu（検索エンジンプラットフォームなどのサービスを提供する中国の多国籍技術企業）が共同開発したAIカメラを使って、眼底疾患を検出するための無料診察を実施しました。このAI眼底カメラは、緑内障、糖尿病網膜症、黄斑変性症を診断できます。

フルオレセイン血管造影は、その代替検査が好まれるにもかかわらず、幅広い眼科疾患の確認検査としてしばしば使用されています。この技術は正確で高品質の画像を提供し、効率的な治療法の選択に役立ちます。さらに、伝統的フルオレセイン血管造影に対する需要は、発展途上国では依然として高いです。これは手頃な価格と製品の入手可能性に起因しています。

フルオレセイン血管造影市場レポートハイライト

• 従来のフルオレセイン血管造影が市場を独占し、2024年には56.4%の最大収益シェアを占めました。
• 加齢黄斑変性（AMD）用途は、高齢化人口の間でこの疾患の有病率が増加しているため、2024年に32.6％の最大の収益シェアを占め、市場で支配的な地位を占めました。
• 病院・クリニックセグメントは市場をリードし、2024年には63.9%の最大収益シェアを占めました。
• 北米のフルオレセイン血管造影市場は世界市場を独占し、2024年に36.4%の最大収益シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 フルオレセイン血管造影市場の変数、動向、範囲

• 市場系統の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ビジネス環境分析
  • 産業分析-ポーターのファイブフォース分析
  • PESTLE分析

第4章 フルオレセイン血管造影市場：タイプビジネス分析

• タイプ市場シェア、2024年と2030年
• タイプセグメントダッシュボード
• 市場規模と予測と動向分析、タイプ別、2018～2030年
• 従来の蛍光眼底造影検査（FA）
• 共焦点走査レーザー眼底検査（cSLO）FA

第5章 フルオレセイン血管造影市場：用途ビジネス分析

• 用途市場シェア、2024年と2030年
• 用途セグメントダッシュボード
• 市場規模と予測と動向分析、用途別、2018～2030年
• 加齢黄斑変性症（AMD）
• 糖尿病網膜症
• 網膜静脈閉塞症
• ぶどう膜炎と網膜血管炎
• 脈絡膜腫瘍
• その他

第6章 フルオレセイン血管造影市場：最終用途ビジネス分析

• 最終用途市場シェア、2024年と2030年
• 最終用途セグメントダッシュボード
• 市場規模と予測と動向分析、最終用途別、2018～2030年
• 病院・クリニック
• 外来手術センター
• その他

第7章 フルオレセイン血管造影市場：地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • デンマーク
  • スウェーデン
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 参加者概要
• 企業の市況分析
• 企業分類
• 戦略マッピング
• 企業プロファイル/上場企業
  • Carl Zeiss Meditec, Inc.
  • NIDEK Co., Ltd.
  • Kowa Company Ltd.
  • Topcon Medical Systems, Inc.
  • Optomed Oy Ltd.
  • CenterVue SpA
  • Canon, Inc.

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Fluorescein Angiography Market, by Region, 2018 - 2030 (USD Million)
• Table 4 Global Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 5 Global Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 6 Global Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 7 North America Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
• Table 8 North America Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 9 North America Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 10 North America Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 11 U.S. Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 12 U.S. Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 13 U.S. Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 14 Canada Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 15 Canada Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 16 Canada Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 17 Mexico Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 18 Mexico Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 19 Mexico Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 20 Europe Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
• Table 21 Europe Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 22 Europe Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 23 Europe Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 24 UK Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 25 UK Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 26 UK Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 27 Germany Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 28 Germany Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 29 Germany Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 30 France Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 31 France Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 32 France Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 33 Italy Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 34 Italy Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 35 Italy Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 36 Spain Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 37 Spain Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 38 Spain Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 39 Norway Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 40 Norway Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 41 Norway Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 42 Denmark Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 43 Denmark Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 44 Denmark Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 45 Sweden Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 46 Sweden Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 47 Sweden Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 52 Japan Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 53 Japan Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 54 Japan Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 55 China Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 56 China Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 57 China Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 58 India Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 59 India Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 60 India Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 61 Australia Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 62 Australia Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 63 Australia Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 64 South Korea Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 65 South Korea Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 66 South Korea Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 67 Thailand Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 68 Thailand Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 69 Thailand Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 70 Latin America Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
• Table 71 Latin America Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 72 Latin America Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 73 Latin America Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 74 Brazil Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 75 Brazil Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 76 Brazil Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 77 Argentina Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 78 Argentina Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 79 Argentina Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 83 Middle East & Africa Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 84 South Africa Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 85 South Africa Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 86 South Africa Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 90 UAE Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 91 UAE Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 92 UAE Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
• Table 93 Kuwait Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
• Table 94 Kuwait Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
• Table 95 Kuwait Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Fluorescein Angiography Market Segmentation
• Fig. 2 Market Research Process
• Fig. 3 Data Triangulation Techniques
• Fig. 4 Primary Research Pattern
• Fig. 5 Market Research Approaches
• Fig. 6 Value-Chain-Based Sizing & Forecasting
• Fig. 7 Market Formulation & Validation
• Fig. 8 Market Snapshot
• Fig. 9 Type, Application Outlook (USD Million)
• Fig. 10 End Use Outlook (USD Million)
• Fig. 11 Competitive Landscape
• Fig. 12 Fluorescein Angiography Market Dynamics
• Fig. 13 Fluorescein Angiography Market: Porter's Five Forces Analysis
• Fig. 14 Fluorescein Angiography Market: PESTLE analysis
• Fig. 15 Fluorescein Angiography Market: Type Segment Dashboard
• Fig. 16 Fluorescein Angiography Market: Type Market Share Analysis, 2024 & 2030
• Fig. 17 Traditional Fluorescein Angiography (FA) Market, 2018 - 2030 (USD Million)
• Fig. 18 Confocal Scanning Laser Ophthalmoscopy (cSLO) FA Market, 2018 - 2030 (USD Million)
• Fig. 19 Fluorescein Angiography Market: Application Segment Dashboard
• Fig. 20 Fluorescein Angiography Market: Application Market Share Analysis, 2024 & 2030
• Fig. 21 Age-related Macular Degeneration (AMD) Market, 2018 - 2030 (USD Million)
• Fig. 22 Diabetic Retinopathy Market, 2018 - 2030 (USD Million)
• Fig. 23 Retinal Vein Occlusion Market, 2018 - 2030 (USD Million)
• Fig. 24 Uveitis and Retinal Vasculitis Market, 2018 - 2030 (USD Million)
• Fig. 25 Choroidal Tumors Market, 2018 - 2030 (USD Million)
• Fig. 26 Others Market, 2018 - 2030 (USD Million)
• Fig. 27 Fluorescein Angiography Market: End Use Segment Dashboard
• Fig. 28 Fluorescein Angiography Market: End Use Market Share Analysis, 2024 & 2030
• Fig. 29 Hospitals and Clinics Market, 2018 - 2030 (USD Million)
• Fig. 30 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
• Fig. 31 Others Market, 2018 - 2030 (USD Million)
• Fig. 32 Fluorescein Angiography Market Revenue, By Region
• Fig. 33 Regional Marketplace: Key Takeaways
• Fig. 34 Regional Marketplace: Key Takeaways
• Fig. 35 North America Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 36 U.S. Country Dynamics
• Fig. 37 U.S. Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 38 Canada Country Dynamics
• Fig. 39 Canada Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 40 Mexico Country Dynamics
• Fig. 41 Mexico Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 42 Europe Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 43 UK Country Dynamics
• Fig. 44 UK Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 45 Germany Country Dynamics
• Fig. 46 Germany Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 47 France Country Dynamics
• Fig. 48 France Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 49 Italy Country Dynamics
• Fig. 50 Italy Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 51 Spain Country Dynamics
• Fig. 52 Spain Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 53 Norway Country Dynamics
• Fig. 54 Norway Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 55 Sweden Country Dynamics
• Fig. 56 Sweden Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 57 Denmark Country Dynamics
• Fig. 58 Denmark Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 59 Asia Pacific Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 60 Japan Country Dynamics
• Fig. 61 Japan Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 62 China Country Dynamics
• Fig. 63 China Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 64 India Country Dynamics
• Fig. 65 India Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 66 Australia Country Dynamics
• Fig. 67 Australia Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 68 South Korea Country Dynamics
• Fig. 69 South Korea Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 70 Thailand Country Dynamics
• Fig. 71 Thailand Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 72 Latin America Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 73 Brazil Country Dynamics
• Fig. 74 Brazil Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 75 Argentina Country Dynamics
• Fig. 76 Argentina Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 77 MEA Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 78 South Africa Country Dynamics
• Fig. 79 South Africa Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 80 Saudi Arabia Country Dynamics
• Fig. 81 Saudi Arabia Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 82 UAE Country Dynamics
• Fig. 83 UAE Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 84 Kuwait Key Country Dynamicss
• Fig. 85 Kuwait Fluorescein Angiography Market, 2018 - 2030 (USD Million)
• Fig. 86 Company Categorization
• Fig. 87 Company Market Position Analysis
• Fig. 88 Strategic Framework

Fluorescein Angiography Market Growth & Trends:

The global fluorescein angiography market size is expected to reach USD 1.39 billion by the end of 2030, expanding at a CAGR of 8.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of ophthalmic conditions such as macular degeneration and diabetic retinopathy and rapid technological advancements are some of the high impact-rendering market drivers. However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.

End-users such as hospitals and imaging centers in the country are effectively adopting AI-based fundus cameras for detecting various blindness-causing diseases. For instance, in January 2019, Deqing County hospital in Guangdong Province conducted a free consultation by featuring an AI camera codeveloped by Sun Yat-sen University and Baidu-a multinational technology company in China that offers services, including a search engine platform-to detect ocular fundus diseases. This AI fundus camera is capable of diagnosing glaucoma, diabetic retinopathy, and macular degeneration.

Despite preference of its alternatives, fluorescein angiography is often used as confirmatory test for a wide range of ophthalmic conditions. The technique provides accurate and high quality pictures which help in selecting efficient treatment regimen. In addition, the demand for tradition fluorescein angiography systems is still high in developing countries. This can be attributed to affordability and product availability.

Fluorescein Angiography Market Report Highlights:

• Traditional fluorescein angiography dominated the market and accounted for the largest revenue share of 56.4% in 2024, attributed to the rising incidence of eye diseases, particularly diabetic retinopathy and age-related macular degeneration.
• The age-related macular degeneration (AMD) application held the dominant position in the market, with the largest revenue share of 32.6% in 2024, owing to the increasing prevalence of this condition among the aging population.
• The hospitals and clinics segment led the market and accounted for the largest revenue share of 63.9% in 2024 attributed to the increasing prevalence of eye diseases, particularly among the aging population.
• The fluorescein angiography market in North America dominated the global market and accounted for the largest revenue share of 36.4% in 2024 attributed to the high prevalence of eye diseases, particularly diabetic retinopathy, which affects millions of individuals.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Fluorescein Angiography Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Fluorescein Angiography Market: Type Business Analysis

• 4.1. Type Market Share, 2024 & 2030
• 4.2. Type Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Traditional Fluorescein Angiography (FA)
  • 4.4.1. Traditional Fluorescein Angiography (FA) Market, 2018 - 2030 (USD Million)
• 4.5. Confocal Scanning Laser Ophthalmoscopy (cSLO) FA
  • 4.5.1. Confocal Scanning Laser Ophthalmoscopy (cSLO) FA Market, 2018 - 2030 (USD Million)

Chapter 5. Fluorescein Angiography Market: Application Business Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Application Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Age-related Macular Degeneration (AMD)
  • 5.4.1. Age-related Macular Degeneration (AMD) Market, 2018 - 2030 (USD Million)
• 5.5. Diabetic Retinopathy
  • 5.5.1. Diabetic Retinopathy Market, 2018 - 2030 (USD Million)
• 5.6. Retinal Vein Occlusion
  • 5.6.1. Retinal Vein Occlusion Market, 2018 - 2030 (USD Million)
• 5.7. Uveitis and Retinal Vasculitis
  • 5.7.1. Uveitis and Retinal Vasculitis Market, 2018 - 2030 (USD Million)
• 5.8. Choroidal Tumors
  • 5.8.1. Choroidal Tumors Market, 2018 - 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Fluorescein Angiography Market: End Use Business Analysis

• 6.1. End Use Market Share, 2024 & 2030
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals and Clinics
  • 6.4.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)
• 6.5. Ambulatory Surgical Centers
  • 6.5.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Fluorescein Angiography Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. UK Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. Germany Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Norway
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Norway Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Denmark Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Sweden
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Sweden Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. Japan Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. China Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. India Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. South Korea Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. Australia Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. Thailand Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Carl Zeiss Meditec, Inc.
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Type Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. NIDEK Co., Ltd.
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Type Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. Kowa Company Ltd.
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Type Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. Topcon Medical Systems, Inc.
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Type Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. Optomed Oy (Ltd.)
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Type Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. CenterVue SpA
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Type Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. Canon, Inc.
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Type Benchmarking
    • 8.5.7.4. Strategic Initiatives